Global Markets Directs, 'Xerosis (Dry Skin) - Pipeline Review, H2 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Xerosis (Dry Skin), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Xerosis (Dry Skin). Xerosis (Dry Skin) - Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases ... Read more »